At the news
? NEUTRALIMPACT 3/10 COURT-RULING filed Jul 13, 2026 at 20:00 ET
A federal magistrate judge has recommended dismissing with prejudice a qui tam False Claims Act lawsuit against Abbott Laboratories, finding that the relators failed to plead with particularity that false claims were submitted as a result of an alleged kickback scheme. The case, which centered on Abbott's spinal cord stimulator devices, represented a minor litigation overhang for the $155B company. The recommendation is expected to be adopted by the district judge, effectively ending the case.
- Magistrate Judge Dustin M. Howell recommended granting Abbott's motion to dismiss with prejudice on July 14, 2026.
- Relators alleged Abbott violated the False Claims Act by providing kickbacks (meals, event expenses) to a pain clinic to induce use of Abbott's spinal cord stimulators.
- The court found relators failed to identify any specific false claim submitted to the government or provide reliable indicia linking the kickback scheme to actual false claims.
- Abbott is the sole remaining defendant after voluntary dismissal of other parties.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access